Iterum Therapeutics PL F

13F holders, Q4 2025 (December 31)
1holders
$0.33avg. 13F price*

At the end of Q4 2025, 1 institutions reported holding Iterum Therapeutics PL F in their 13F filings. The largest holder was Byrne Asset Management LLC ($1).

Company
Iterum Therapeutics PL F
CUSIP
45885H206
Latest filing quarter
Q4 2025

Total Exit/New Position Q4 2025

InstitutionsTotal Value
New Positions1$1
Exits0$0

Ownership 1 holders

Byrne Asset Management LLC 0.00% New 3 $1

"% of holder's portfolio" is ITERUM THERAPEUTICS PL F's weight in each manager's 13F, not the share of Iterum Therapeutics PL F the manager owns.